Summary
Isosorbide dinitrate 10 mg, isosorbide 5-mononitrate 5 mg and isosorbide 2-mononitrate 5 mg were administered orally to subjects with and without renal failure, and the plasma concentrations of isosorbide dinitrate and of both the mononitrates were measured. There was no striking difference in plasma concentration as a function of time between subjects with and without renal failure, except for a somewhat higher isosorbide 5-mononitrate concentration after administration of this metabolite to uraemic patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rosseel M-T, Bogaert MG (1973) GLC Determination of nitroglycerin and isosorbide dinitrate in human plasma. J Pharm Sci 62: 754–758
Chasseaud LF, Down WH, Grundy RK (1975) Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects. Eur J Clin Pharmacol 8: 157–160
Assinder DF, Chasseaud LF, Taylor T (1977) Plasma isosorbide dinitrate concentrations in human subjects after administration of standard and sustained-release formulations. J Pharm Sci 66: 775–778
Chin DA, Prue DG, Michelucci J, Kho BT, Warner CR (1977) Quantitative determination of isosorbide dinitrate and two metabolites in plasma. J Pharm Sci 66: 1143–1145
Malbica JO, Monson K, Neilson K, Sprissler R (1977) Electron-capture GLC determination of nanogram to picogram amounts of isosorbide dinitrate. J Pharm Sci 66: 384–386
Laufen H, Scharpf F, Bartsch G (1978) Improved method for the rapid determination of isosorbide dinitrate in human plasma and its application in pharmacokinetic studies. J Chromatogr 146: 457–464
Mansel-Jones D, Taylor T, Doyle E, Chasseaud LF, Darragh A, O'Kelly DA, Over H (1978) Plasma concentrations of isosorbide dinitrate after cutaneous and sublingual doses to human subjects. J Clin Pharmacol 18: 544–548
Orr JM, Klein GP, Shaar SF (1978) Plasma concentrations of isosorbide dinitrate and two major metabolites following oral administration of two formulations of isosorbide dinitrate tablets. Can J Pharm Sci 13: 45–47
Shane SJ, Iazzetta JJ, Chisholm AW, Berka JF, Leung D (1978) Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man. Br J Clin Pharmacol 6: 37–41
Bogaert MG, Rosseel M-T (1980) Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate. Nouv Presse Med 9: 2424–2427
Thadani U, Manyari D, Parker JO, Fung H-L (1980) Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate. Circulation 61: 526–535
Spörl-Radun S, Betzien G, Kaufmann B, Liede V, Abshagen U (1980) Effects and pharmacokinetics of isosorbide dinitrate in normal man. Eur J Clin Pharmacol 18: 237–244
Bogaert MG, Rosseel M-T (1972) Vascular effects of the dinitrate and mononitrate esters of isosorbide, isomannide and isoidide. Naunyn Schmiedeberg Arch Exp Pathol 275: 339–342
Stauch M, Grewe N (1979) Die Wirkung von Isosorbiddinitrat, Isosorbid-2- und 5-Mononitrat auf das Belastungs-Ekg und auf die Hämodynamik während Vorhofstimulation bei Patienten mit Angina pectoris. Z Kardiol 68: 687–693
Bogaert MG, Rosseel M-T, Teirlynck O (1980) Fate of isosorbide mononitrates in man. In: Proceedings of the 3rd Int Symp Nitrates, Monte Carlo, June 5–7 (in press)
Abshagen U, Spörl-Radun S (1980) Pharmacokinetics and effect of 5-isosorbide-mononitrate (5-ISMN) in normal man. In: Turner P, Padgham C (eds) World Conference on Clinical Pharmacology and Therapeutics, Abstracts. London, August 3–9, 1980. Macmillan, London
Rosseel M-T, Bogaert MG (1979) Simultaneous determination of isosorbide dinitrate and its mononitrates in human plasma by capillary column GLC. J Pharm Sci 68: 659–660
Down WH, Chasseaud LF, Grundy RK (1974) Biotransformation of isosorbide dinitrate in humans. J Pharm Sci 63: 1147–1149
Taylor T, Chasseaud LF, Doyle E, Darragh A, O'Kelly DA, Fitzgerald D (1980) Pharmacokinetics of isosorbide dinitrate after intravenous infusion in human subjects. Biopharm Drug Dispos 1: 149–156
Chasseaud LF, Taylor T (1980) Plasma concentrations and comparative bioavailability of isosorbide dinitrate after sublingual, oral or cutaneous doses to human subjects. In: Rudolph W, Schrey A (eds) Nitrate II. Wirkung auf Herz und Kreislauf. 2. Nitrat-Symposion Berlin, Juni 1978. Urban & Schwarzenberg, München, pp 22–28
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bogaert, M.G., Rosseel, M.T., Boelaert, J. et al. Fate of isosorbide dinitrate and mononitrates in patients with renal failure. Eur J Clin Pharmacol 21, 73–76 (1981). https://doi.org/10.1007/BF00609591
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609591